Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined With Pelvic Irradiation in High-risk Prostate Cancers

NCT00223171 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT00223171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined With Pelvic Irradiation in High-risk Prostate Cancers
Lead sponsor
Université de Sherbrooke
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 31, 2000
Completion date
December 31, 2027
Enrollment
630 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer